This week, Yannis Valtis joined us for a short conversation about a new paper he and colleagues recently published in BMJ Global Health. Their study Read More
The malaria burden in Bhutan decreased significantly during the study period with high coverage of long-lasting insecticidal nets. The foreseeable challenges that require national attention to maintain a malaria-free status after elimination are importation of malaria, especially from India; continued protection of the population in endemic districts through complete coverage with long-lasting insecticidal nets and indoor residual spraying; and exploration of local funding modalities post-elimination in the event of a reduction in international funding.
Motherboard: Malaria’s Last Stand: Will We Defeat Malaria? “…Malaria’s Last Stand is an expository look at the ongoing burden of one of humanity’s oldest diseases. Staff writer Kaleigh Rogers traveled to Tanzania to capture the scope of malaria’s impact on the road to elimination” (6/27).
Friends of the Global Fight Against AIDS, Tuberculosis and Malaria: France, Italy Announce Robust Pledges Ahead of Global Fund’s Fifth Replenishment Sarah Marston, director of communications at Friends of the Global Fight, discusses the government of France’s announcement of a pledge of €1.08 billion and the government of Italy’s announcement of a pledge of €130…More
Infant mortality in rural areas of Nigeria can be minimized if childhood febrile conditions are treated by trained health personnel, deployed to primary healthcare centres (PHCs) rather than the observed prefe…
The Guardian: Malaria scheme cuts child deaths during Sahel’s rainy season “…The innovative Access-SMC project, funded by Unitaid and run by the Malaria Consortium in partnership with Catholic Relief Services, involves scaling up the use of seasonal malaria drugs to children under five in seven countries along the arid belt of land that fringes the…More
Photo by Rebecca E. Rollins / Partners In HealthA view of the maternity ward at J.J. Dossen Memorial Hospital in southeast Liberia in 2015. PIH is nearly finished with a six-month remodel of the hospital.
No one knows for certain the full implications of Britain’s narrow vote to leave the European Union (EU). Since Britain has been a major player in malaria research and development aid, questions naturally arise of whether the British exit (Brexit) from the EU will affect development aid and global research generally and malaria aid and research specifically. Earlier this week the Brookings Institution examined the ways that a Brexit could affect Africa. Here are some of the possibilities adapted to malaria – Volatility in the global economic market will affect not only the British economy but also those of malaria endemic countries, possibly reducing the reducing available funds for national contributions to malaria control at home, a major goal for sustaining malaria control and elimination Britain specifically may not be able to sustain its financial contributions to malaria aid through the Global Fund, bilateral malaria programs and of course it would no longer contribute to the European Development Fund which currently stands at nearly 15% of its total. The British economy which like all modern nations depends on trade would be affected by the need to renegotiate hundreds of trade agreements around the world.
Reuters: GAVI alliance offers matched funds for GSK malaria vaccine pilot “The GAVI global vaccine alliance has offered funding of up to $27.5 million for pilot tests of GlaxoSmithKline’s first-generation malaria vaccine, but only if other organizations promise to match that commitment…” (Kelland, 6/23).
Agence France-Presse: Drug-resistant malaria strain confined to Asia: scientists “A parasite resistant to the top anti-malaria drug is confined to Southeast Asia and has not yet spread to sub-Saharan Africa as feared, said researchers Wednesday. … An international consortium supported by the World Health Organization conducted the research in 59 endemic countries…” (Santini, 6/22).
Categories: U.S. Policy and FundingIn a year when global health leaders have projected a need to extend HIV and tuberculosis services to millions more people, a draft spending bill for the fiscal year beginning October 1 proposes keeping funding for global AIDS and tuberculosis programs and for the Global Fund to Fight AIDS, Tuberculosis and Malaria exactly where it […](Read more…)
Sulfadoxine–pyrimethamine (SP) is recommended for prophylactic treatment of malaria in pregnancy while artemisinin combination therapy is the recommended first-line anti-malarial treatment.
Success in the war against malaria is not guaranteed. Two articles to that effect have appeared The Citizen of Dar es Salaam following presentation of findings from the most recent (2015-16) Tanzania Demographic and Health Survey (DHS)/Malaria Indicator Survey (MIS). On Tuesday (21 June 2016) the news story noted the increase in malaria prevalence among children below the age of 5 years, which was attributed to “the decline in the use of mosquito nets and low distribution of nets to households.” Then in a Wednesday (22 June 2016) Editorial, the paper noted that this “backtracking” is a “worrisome situation, for malaria is a problem that puts such a heavy burden on the government and the country’s economy.” A look at the preliminary DHS does confirm the concerns about insecticide treated nets (ITNs). After nearly 10 years of progress, reported ITN availability in households declined. This was reflected in a drop in reported use by children below 5 years of age as well as pregnant women. It should be noted that targets set in 2000 in the Roll Back Malaria Abuja Declaration had been 80% by the year 2010, and those had almost been achieved in 2012, but the fall to around 50% in 2015-16 is discouraging
Augustine Ngindu, the Technical Advisor for Malaria in Kenya’s Maternal and Child Survival Program (USAID, Jhpiego) shares with us the steps and processes in building a national response to controlling malaria in pregnancy (MIP) in Kenya. Recently Stephanie Dellicour and colleagues wrote about the challenges in the delivery of interventions to prevent malaria in pregnancy in Kenya in Malaria Journal. They examined MIP services in Nyanza Province of western Kenya between February and May 2010. At that time they found that, “… delivery of IPTp (intermittent preventive treatment in pregnancy) and ITNs (insecticide treated nets) through ANC (antenatal care) was ineffective and more so for higher-level facilities.
Despite largely successful control efforts, malaria remains a significant public health problem in Thailand.